Epirubicin and ejection fraction decreased Patient Reports February 12, 2012

Epirubicin Side Effects Report #5492822-3
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 10, 2007. Female patient was diagnosed with lung neoplasm and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, brain natriuretic peptide increased, cardiac failure acute, cough, dilatation ventricular, ejection fraction decreased, gallop rhythm present, hepatic function abnormal, hyperhidrosis. Epirubicin dosage: 450 MG/M2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE. Patient recovered.

Epirubicin Side Effects Report #5921037-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 06, 2008. Female patient, 57 years of age, was diagnosed with breast cancer recurrent and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: unknown. During the same period patient was treated with VINORELBINE, CAPECITABINE, TRASTUZUMAB, GOSERELIN, ANASTROZOLE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5909442-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 24, 2008. Female patient, 57 years of age, was diagnosed with breast cancer metastatic and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: breast cancer metastatic, cardiac failure, cerebellar ataxia, disease progression, ejection fraction decreased, lymphoedema. Epirubicin dosage: unknown. During the same period patient was treated with CAPECITABINE, TRASTUZUMAB, VINORELBINE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4693617-0
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased. Epirubicin dosage: 100 MG/M2 PER CYCLE. During the same period patient was treated with PACLITAXEL. Patient recovered.


Epirubicin Side Effects Report #4693618-2
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 100 MG/M2 PER CYCLE. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693637-6
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient died.

Epirubicin Side Effects Report #4693640-6
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693642-X
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.

Epirubicin Side Effects Report #4693647-9
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.


Epirubicin Side Effects Report #4693653-4
Epirubicin side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, ejection fraction decreased. Epirubicin dosage: 90 MG/M2 PER_CYCLE IV. During the same period patient was treated with PACLITAXEL. Patient recovered.